PMV Pharmaceuticals, Inc.PMVPEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

PMV Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing precision oncology therapies targeting mutations in the p53 tumor suppressor gene, one of the most frequently altered genes in human cancers. Its lead product candidates address unmet medical needs for patients with hard-to-treat solid and hematologic malignancies, serving global oncology patient segments.